electroCore (ECOR) Income from Continuing Operations (2017 - 2026)
electroCore's (ECOR) quarterly Income from Continuing Operations came in at 5271000.0 in Q1 2026, down 36.73% year-on-year from 8331162.36 in Q1 2025, and down 149.31% quarter-over-quarter from 10689000.0 in Q4 2025.
electroCore (ECOR) Income from Continuing Operations (2017 - 2026) Analysis & Trends
electroCore's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 5271000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 36.73% year-over-year to 5271000.0 in Q1 2026; TTM through Mar 2026 was 1658000.0, a 85.7% increase from a year earlier, with the FY2025 full-year figure at 242000.0, up 97.85% from the prior year.
- Income from Continuing Operations eased to 5271000.0 in Q1 2026 per ECOR's latest filing, from 10689000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 10689000.0 in Q4 2025 and bottomed at 5867000.0 in Q1 2023.
- The 5-year median for Income from Continuing Operations is 3855000.0 (2025), against an average of 3379235.29.
- Across the five-year window, Income from Continuing Operations sank 149.35% in 2022 and soared 513.18% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 5790000.0 in 2022, then jumped by 35.66% to 3725000.0 in 2023, then soared by 30.55% to 2587000.0 in 2024, then surged by 513.18% to 10689000.0 in 2025, then plunged by 149.31% to 5271000.0 in 2026.
- Per Business Quant, the three latest ECOR Income from Continuing Operations figures stand at 5271000.0 (Q1 2026), 10689000.0 (Q4 2025), and 3405000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn | -5.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.27 Mn |
| Dec 31, 2025 | 10.69 Mn |
| Sep 30, 2025 | -3.41 Mn |
| Jun 30, 2025 | -3.67 Mn |
| Mar 31, 2025 | -3.86 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Sep 30, 2024 | -2.50 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Dec 31, 2023 | -3.73 Mn |
| Sep 30, 2023 | -4.03 Mn |
| Jun 30, 2023 | -4.90 Mn |
| Mar 31, 2023 | -5.87 Mn |
| Dec 31, 2022 | -5.79 Mn |
| Sep 30, 2022 | -5.45 Mn |
| Jun 30, 2022 | -5.34 Mn |
| Mar 31, 2022 | -5.58 Mn |
| Dec 31, 2021 | 11.73 Mn |
| Sep 30, 2021 | -3.99 Mn |
| Jun 30, 2021 | -2.89 Mn |